Approximately 10% to 15% of HR-positive, HER2-negative breast cancer patients experience visceral crises,[11] which may present with diffuse liver metastases, meningeal involvement, bone marrow infiltration, or pulmonary lymphangitic carcinomatosis (PLC). The gene discussed is ERBB2; the disease is breast cancer.